Gaining acceptance in next generation PBK modelling approaches for regulatory assessments – An OECD international effort

Physiologically Based Kinetic (PBK) models are valuable tools to help define safe external levels of chemicals based on internal doses at target organs in experimental animals, humans and organisms used in environmental risk assessment. As the toxicity testing paradigm shifts to alternative testing approaches, PBK model development has started to rely (mostly or entirely) on model parameters quantified using in vitro or in silico methods. Recently, the Organisation for Economic Cooperation and Development (OECD) published a guidance document (GD) describing a scientific workflow for characterising and validating PBK models developed using in vitro and in silico data. The GD provides an assessment framework for evaluating these models, with emphasis on the major uncertainties underlying model inputs and outputs. To help end-users submit or evaluate a PBK model for regulatory purposes, the GD also includes a template for documenting the model characteristics, and a checklist for evaluating the quality of a model. This commentary highlights the principles, criteria and tools laid out in the OECD PBK model GD, with the aim of facilitating the dialogue between model developers and risk assessors.

PAINI Alicia;  TAN Yu-Mei;  SACHANA Magda;  WORTH Andrew; 

2021-03-22

ELSEVIER BV

JRC122586

2468-1113 (print),   

https://www.sciencedirect.com/science/article/pii/S2468111321000116?via%3Dihub,    https://publications.jrc.ec.europa.eu/repository/handle/JRC122586,   

10.1016/j.comtox.2021.100163 (online),